Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unilateral vs Bilateral Hippocampal Avoidance WBRT + Memantine for Brain Metastases
NCT04801342Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2021
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Hopkins Verbal Learning Test-Revised memory score at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT04801342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801342.